98%
921
2 minutes
20
Introduction: Breast cancer typically metastasizes to axillary, internal mammary and supraclavicular lymph node chains. In contrast, occult breast cancer (OBC), a rare form of breast cancer, usually presents as axillary lymphadenopathy and rarely metastasizes regionally or distally.
Case Presentation: In this case report, we present a 45-year-old female patient with unusual presentation of breast cancer initially as axillary lymphadenopathy without breast mass. She was diagnosed by magnetic resonance imaging as OBC and later presented with a rare pathological spread to the ipsilateral subscapular region. The retro-scapular nodal disease was first detected via follow-up computed tomography scan and confirmed by positron emission tomography after 18 months of her initial diagnoses. This occurred following completion of OBC management, which included neoadjuvant chemotherapy, axillary lymph node dissection, without mastectomy, followed by adjuvant radiation treatment to regional lymph nodes and ipsilateral whole breast. Her recurrent nodal disease was subsequently managed by surgical resection followed by radiation therapy to surgical bed.
Conclusion: This case report emphasizes the diverse locations where metastatic breast cancer can manifest and underscores the advancements in diagnostic tools that have enhanced the detection of these metastatic sites.
Download full-text PDF |
Source |
---|---|
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11828488 | PMC |
http://dx.doi.org/10.1159/000543346 | DOI Listing |
JMIR Res Protoc
September 2025
Department of Health Services Research & Administration, College of Public Health, University of Nebraska Medical Center, Omaha, NE, United States.
Background: With the availability of more advanced and effective treatments, life expectancy has improved among patients with metastatic breast cancer (MBC), but this makes communication with their medical oncologist more complex. Some patients struggle to learn about their therapeutic options and to understand and articulate their preferences. Mobile health (mHealth) apps can enhance patient-provider communication, playing a crucial role in the diagnosis, treatment, quality of life, and outcomes for patients living with MBC.
View Article and Find Full Text PDFCancer Epidemiol Biomarkers Prev
September 2025
Kangbuk Samsung Hospital, Seoul, Korea (South), Republic of.
Background: Iron metabolism may influence breast cancer development; however, links between iron-related biomarkers and breast cancer remain inconclusive. Given differences in iron status by menopausal status, we examined associations of ferritin and other iron biomarkers, with breast cancer incidence, stratified by menopausal status, in a Korean screening cohort.
Methods: This cohort study included 140,747 Korean women screened for breast cancer from 2011-2020.
Cancer Epidemiol Biomarkers Prev
September 2025
National Cancer Institute, Bethesda, MD, United States.
Background: Alcohol consumption is a risk factor for certain cancers and is increasing in the United States. We estimated the impact of alcohol consumption on cancer incidence trends in the United States from 2008-2019 across six alcohol-related cancers among men and women.
Methods: Average daily alcohol consumption (ADC) was calculated from the National Health Interview Survey (NHIS, 1998-2009) and adjusted to per capita sales data to account for underreporting alcohol use.
Cell Mol Biol (Noisy-le-grand)
September 2025
Assistant Professor of General Surgery, Department of Surgery, College of Medicine, University of Duhok, Kurdistan Region, Iraq.
Hormonal status and lymphatic invasion are two important prognostic factors among cases of breast cancer. This study aims to assess and evaluate the hormonal receptor status and lymph node involvement among female breast cancer patients in Duhok city, Kurdistan region, Iraq. A retrospective cross-sectional study was conducted, involving 156 diagnosed cases of breast cancer who had undergone surgical treatment and laboratory investigations at Azadi Teaching Hospital and Duhok Private Hospital for 30 months.
View Article and Find Full Text PDFRadiol Med
September 2025
Breast Imaging Division, Radiology Department, IEO European Institute of Oncology IRCCS, 20141, Milan, Italy.
Metastatic involvement (MB) of the breast from extramammary malignancies is rare, with an incidence of 0.09-1.3% of all breast malignancies.
View Article and Find Full Text PDF